Nature Reviews Drug Discovery 15, 147–149 (2016)
Martin Dyer's affiliation was incorrect. He is at the University of Leicester, UK. This has been corrected in the online version of the article.
Additional information
The online version of the original article can be found at 10.1038/nrd.2016.23
Rights and permissions
About this article
Cite this article
Mullard, A. Erratum: Pioneering apoptosis-targeted cancer drug poised for FDA approval. Nat Rev Drug Discov 15, 292 (2016). https://doi.org/10.1038/nrd.2016.53
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2016.53
